Back to top
more

Medpace (MEDP)

(Delayed Data from NSDQ)

$326.26 USD

326.26
759,723

+5.68 (1.77%)

Updated Sep 26, 2024 04:00 PM ET

After-Market: $326.58 +0.32 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (164 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Zacks Industry Outlook Highlights Medpace, HealthEquity and Surgery Partners

Medpace, HealthEquity and Surgery Partners are part of the Zacks Industry Outlook article.

Zacks.com featured highlights include Medpace, Invitation Home and Ryanair

Medpace, Invitation Home and Ryanair are part of the Zacks Screen of the Week article.

Urmimala Biswas headshot

3 Medical Services Stocks Countering Industry-Wide Headwinds

The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and SGRY are set to gain the most. However, staffing shortages may disrupt the trend.

Tirthankar Chakraborty headshot

3 Top Stocks Exhibiting Superb Earnings Growth

Invest in stocks such as Medpace Holdings (MEDP), Invitation Home (INVH) and Ryanair Holdings (RYAAY) for solid earnings growth.

Acadia Healthcare (ACHC) Up 11% in 3 Months: More Room to Run?

Acadia Healthcare (ACHC) is well-poised for growth on an expansive healthcare portfolio, which in turn, boosts its patient volumes.

3 Reasons Growth Investors Will Love Medpace (MEDP)

Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.

Medpace (MEDP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Medpace (MEDP), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

Here is how McKesson (MCK) and Medpace (MEDP) have performed compared to their sector so far this year.

Medpace (MEDP) Surpasses Q2 Earnings and Revenue Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 1.58% and 6.99%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

GoodRx Holdings, Inc. (GDRX) Soars 21.5%: Is Further Upside Left in the Stock?

GoodRx Holdings, Inc. (GDRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Medpace (MEDP) is a Great Momentum Stock: Should You Buy?

Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Industry Outlook Highlights Medpace, HealthEquity and Apollo Medical

Medpace, HealthEquity and Apollo Medical are part of the Zacks Industry Outlook article.

Brookdale (BKD) May 2023 Occupancy Rises: Better Days Ahead?

Brookdale (BKD) has witnessed 19 straight months of year-over-year increases in weighted average occupancy level.

Urmimala Biswas headshot

3 Medical Services Stocks to Buy Amid Improving Industry Trends

The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and AMEH are set to gain the most. However, staffing shortages may disrupt the trend.

Humana (HUM) Arm Reaches 250 Senior Primary Care Facilities

Humana's (HUM) CenterWell business focuses on providing a better healthcare experience through clubbing primary care, home health and pharmacy services.

Should You Retain Acadia Healthcare (ACHC) in Your Portfolio?

Acadia Healthcare's (ACHC) top line is likely to receive support from growth in specialty treatment and acute inpatient psychiatric facilities.

Here's Why Investors Should Hold Encompass Health (EHC) Now

Encompass Health (EHC) remains well-poised for growth, attributable to expanding patient admissions, robust expansion endeavors and strong cash-generating abilities.

Here's Why You Should Hold Elevance (ELV) in Your Portfolio

Improving top line, investments in high-growth businesses, membership hikes and significant new contracts in its government business poise Elevance Health (ELV) well for growth.

Here is Why Growth Investors Should Buy Medpace (MEDP) Now

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.

New Strong Buy Stocks for May 3rd

COCO, RYI, GTX, MEDP and SKX have been added to the Zacks Rank #1 (Strong Buy) List on May 3rd, 2023.

All You Need to Know About Medpace (MEDP) Rating Upgrade to Strong Buy

Medpace (MEDP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Medpace (MEDP) Beats Q1 Earnings and Revenue Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 28.98% and 8.37%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TRxADE (MEDS) Reports Q4 Loss, Tops Revenue Estimates

TRxADE (MEDS) delivered earnings and revenue surprises of -66.67% and 8.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Medpace (MEDP) Tops Q4 Earnings and Revenue Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 19.10% and 2.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?